The development and preparation of a quality control dossier for registration of Artemisia Afra capsules for the treatment of chronic Asthma by the South African health products regulatory authority

dc.contributor.advisorSyce, James
dc.contributor.authorSekhonyana-Khetsekile, Mabolaeng
dc.date.accessioned2018-09-27T09:04:29Z
dc.date.accessioned2024-05-15T07:42:52Z
dc.date.available2018-12-31T22:10:06Z
dc.date.available2024-05-15T07:42:52Z
dc.date.issued2018
dc.descriptionMagister Pharmaceuticae - Mpharm
dc.description.abstractThe aim of this study was to determine quality control specifications needed for a dossier and an investigator's brochure of A. afra capsules, which can be used to motivate the registration and clinical testing of A. afra capsules in chronic asthma. The specific objectives were: (1) to establish the minimum product quality requirements for registration of A. afra capsules, (2) to prepare and pharmaceutically characterize a capsule product of A. afra freeze dried aqueous extract (FDAE) suitable for registration, and (3) to identify pharmaceutical product quality aspects of an investigator's brochure (IB) that would be appropriate for use in motivating a clinical trial of A. afra capsules in chronic asthma.
dc.identifier.urihttps://hdl.handle.net/10566/15150
dc.language.isoen
dc.publisherUniversity of the Western Cape
dc.rights.holderUniversity of the Western Cape
dc.subjectArtemisia afra, Freeze dried aqueous extract, Quality control, Herbal capsules, South African Medicines Control Council / South African Health Products Regulatory Authority, Dossier, Investigational Drug Brochure
dc.titleThe development and preparation of a quality control dossier for registration of Artemisia Afra capsules for the treatment of chronic Asthma by the South African health products regulatory authority

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2860-3489-2-RV.pdf
Size:
2.5 MB
Format:
Adobe Portable Document Format